Drug delivery and release systems for targeted tumor therapy

D Böhme, AG Beck‐Sickinger - Journal of Peptide Science, 2015 - Wiley Online Library
Most toxic agents currently used for chemotherapy show a narrow therapeutic window,
because of their inability to distinguish between healthy and cancer cells. Targeted drug …

Drug delivery and release systems for targeted tumor therapy

D Böhme, AG Beck‐Sickinger - Journal of Peptide Science, 2015 - infona.pl
Most toxic agents currently used for chemotherapy show a narrow therapeutic window,
because of their inability to distinguish between healthy and cancer cells. Targeted drug …

Drug delivery and release systems for targeted tumor therapy.

D Böhme, AG Beck-Sickinger - Journal of Peptide Science: an …, 2015 - europepmc.org
Most toxic agents currently used for chemotherapy show a narrow therapeutic window,
because of their inability to distinguish between healthy and cancer cells. Targeted drug …

Drug delivery and release systems for targeted tumor therapy

D Böhme, AG Beck-Sickinger - Journal of peptide …, 2015 - pubmed.ncbi.nlm.nih.gov
Most toxic agents currently used for chemotherapy show a narrow therapeutic window,
because of their inability to distinguish between healthy and cancer cells. Targeted drug …

Drug delivery and release systems for targeted tumor therapy

D Böhme, AG Beck‐Sickinger - Journal of Peptide Science, 2015 - cir.nii.ac.jp
抄録< jats: p> Most toxic agents currently used for chemotherapy show a narrow therapeutic
window, because of their inability to distinguish between healthy and cancer cells. Targeted …